Volume 68, Issue 6, Pages (December 2005)

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter.

Beta blockers in the management of chronic kidney disease

Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter.

From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria Paul E. De Jong, Barry M. Brenner Kidney International

Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy G. Viglino, L. Neri, S. Barbieri Kidney.

Volume 80, Issue 10, Pages (November 2011)

Progression of renal failure and hypertensive nephrosclerosis

Volume 77, Issue 1, Pages 6-8 (January 2010)

Volume 68, Issue 4, Pages (October 2005)

Volume 63, Issue 3, Pages (March 2003)

Better nephrology for mice—and man

Is there a pharmacologic basis for combination renin axis blockade?

Jeffrey C. Fink, Glenn M. Chertow Kidney International

The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age B.O. Eriksen, O.C. Ingebretsen Kidney International

Volume 77, Issue 1, Pages 5-6 (January 2010)

Progression of diabetic nephropathy

How to interpret the eGFR in patients with small body surface area

Volume 64, Issue 5, Pages (November 2003)

Anemia as a risk factor for chronic kidney disease

Comorbidity and confounding in end-stage renal disease

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

A new era in phosphate binder therapy: What are the options?

Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought Nicolas Rognant, Maurice Laville Kidney.

Volume 70, Issue 11, Pages (December 2006)

Prediabetes as a Precursor to Diabetic Kidney Disease

Volume 59, Issue 3, Pages (March 2001)

Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease S. Bianchi, R. Bigazzi, V.M. Campese

Volume 63, Issue 6, Pages (June 2003)

Volume 70, Issue 12, Pages (December 2006)

Volume 84, Issue 1, Pages (July 2013)

Fructose intake as a risk factor for kidney stone disease

Volume 60, Issue 4, Pages (October 2001)

Volume 57, Issue 1, Pages (January 2000)

Alfonso M. Cueto-Manzano, Héctor R

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 64, Issue 1, Pages (July 2003)

Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske

Volume 56, Issue 2, Pages (August 1999)

The global challenge of chronic kidney disease

Volume 68, Issue 4, Pages (October 2005)

Volume 57, Issue 1, Pages (January 2000)

Unilateral renal cystic disease

Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark

Volume 58, Issue 5, Pages (November 2000)

Volume 56, Issue 3, Pages (September 1999)

Volume 66, Issue 5, Pages (November 2004)

Volume 87, Issue 1, Pages (January 2015)

Volume 80, Issue 10, Pages (November 2011)

Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction Malcolm F. Hand, William G. Haynes, David J.

Treatment of the primary hyperoxalurias: A new chapter

Is complement a target for therapy in renal disease?

Volume 70, Issue 6, Pages (September 2006)

Mild renal insufficiency is associated with reduced coronary flow in patients with non- obstructive coronary artery disease A.R. Chade, D. Brosh, S.T.

H.J. Chin, H. Ro, H.J. Lee, K.Y. Na, D.-W. Chae Kidney International

Erratum Kidney International Volume 61, Issue 4, (April 2002)

Volume 72, Issue 11, Pages (December 2007)

Thomas C. Dowling, Reginald F. Frye, Donald S. Fraley, Gary R. Matzke

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Renal vascular disease in the elderly

Volume 53, Issue 5, Pages (May 1998)

Temporal adaptation of tubuloglomerular feedback: Effects of COX-2

Volume 57, Pages S44-S48 (April 2000)

Volume 71, Issue 3, Pages (February 2007)

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Volume 64, Issue 6, Pages (December 2003)

Presentation transcript:

Volume 68, Issue 6, Pages 2773-2780 (December 2005) Early detection of progressive renal dysfunction in patients with coronary artery disease Giorgio Fuiano, Domenico Mancuso, Ciro Indolfi, Annalisa Mongiardo, Massimo Sabbatini, Giuseppe Conte, Luca De Nicola, Roberto Minutolo, Giuseppe Mazza, Paola Cianfrone, Michele Andreucci Kidney International Volume 68, Issue 6, Pages 2773-2780 (December 2005) DOI: 10.1111/j.1523-1755.2005.00748.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Values of basal GFR and RPF according to number of significant coronary stenoses (SCS). (Kruskal Wallis analysis with Dunn's multiple comparison test). Kidney International 2005 68, 2773-2780DOI: (10.1111/j.1523-1755.2005.00748.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Single values of PAH clearance in CAD patients and in C subjects at baseline and after AA infusion. Horizontal lines represent the median values; P values indicate the statistical difference between baseline and after AA. Kidney International 2005 68, 2773-2780DOI: (10.1111/j.1523-1755.2005.00748.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Single values of inulin clearance in CAD patients and in C subjects at baseline and after AA infusion. Horizontal line represents the median value; P values indicate the statistical difference between baseline and after AA. N.S. NS, not significant. Kidney International 2005 68, 2773-2780DOI: (10.1111/j.1523-1755.2005.00748.x) Copyright © 2005 International Society of Nephrology Terms and Conditions